Quidel | QDEL - Operating Profit


Quidel reported $-37.3M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Agilent USD 353M 90M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Danaher USD 1.34B 158M Mar/2026
Haemonetics USD 67.4M 8.9M Dec/2025
Illumina USD 256M 6M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quidel USD -37.3M 667.5M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
STAAR Surgical USD -10.93M 29.42M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Waters USD 270.52M 78.4M Dec/2025